Abbonarsi

Photon-counting CT-derived extracellular volume in acute myocarditis: Comparison with cardiac MRI - 02/07/25

Doi : 10.1016/j.diii.2025.03.001 
Christos Gkizas a, , Benjamin Longere a, b, Olga Sliwicka a, Aimee Rodriguez Musso a, Gilles Lemesle b, c, Cedric Croisille d, Mehdi Haidar a, Francois Pontana a, b
a Department of Cardiovascular Imaging, Heart and Lung Institute, University Hospital of Lille, 59000 Lille, France 
b INSERM UMR 1011, Institute Pasteur of Lille, EGID (European Genomic Institute for Diabetes), FR3508; Univ Lille, 59000, Lille, France 
c Cardiac Intensive Care Unit and Hemodynamic Center, Heart and Lung Institute, University Hospital of Lille, 59000, Lille, France 
d Siemens Healthineers, 33600, Bordeaux, France 

Corresponding author.

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
Articolo gratuito.

Si connetta per beneficiarne

Highlights

Extracellular volume calculation using iodine maps from late enhancement by cardiac dual-source photon-counting detector computed tomography is feasible.
Excellent correlation is found between photon-counting detector computed tomography and magnetic resonance imaging for the estimation of extracellular volume in patients with myocarditis.
A two-acquisition protocol with a 5-minute delay late enhancement acquisition could accurately assess myocarditis.

Il testo completo di questo articolo è disponibile in PDF.

Abstract

Purpose

The purpose of this study was to evaluate the feasibility and the accuracy of myocardial late iodine enhancement for extracellular volume (ECV) quantification using dual-source photon-counting detector computed tomography (PCD-CT) in patients with suspected acute myocarditis by comparison with cardiac MRI.

Materials and methods

Patients with clinical suspicion of myocarditis who were referred for coronary CT angiography (CCTA) to exclude coronary artery disease were included in this retrospective study. All patients underwent CCTA examination using a first-generation PCD-CT, which included slate iodine enhancement images. ECV was calculated from the iodine ratio of the myocardium to the blood pool on late iodine enhancement PCD-CT images. A comprehensive cardiac MRI protocol was used as the reference method to confirm myocarditis according to the Lake Louise 2018 criteria. All subjects underwent CCTA using PCD-CT and cardiac MRI within 24 h. The mean dose-length product of late enhancement PCD-CT scanning was calculated. Correlations between ECV PCD-CT (endocardial, epicardial, midcardial, and global), cardiac MRI-LGE, and right and left ventricular ejection fractions were assessed using Pearson correlation test. ECV values derived from PCD-CT and those from cardiac MRI were compared using Bland Altman plots and linear regression analysis. Areas under the receiver operating characteristic curves (AUCs) were used to determine the optimal thresholds of ECV-PCD-CT and ECV-MRI for differentiating patients with myocarditis from those not meeting the Lake Louise criteria.

Results

Thirty-two patients were included. There were 19 men and 13 women with a mean age of 35.9 ± 15.0 (standard deviation [SD]) years; age range: 21–51). The mean dose-length product of late enhancement PCD-CT scanning was 96 ± 32 (SD) mGy.cm. No significant differences in mean global ECV were found between ECV calculated with the PCD-CT (29.4 ± 4.5 [SD] %) and that calculated with cardiac MRI (30.0 ± 4.1 [SD] %) ( P = 0.69). ECV-CT was greater in patients with cardiac MRI-confirmed myocarditis (31.65 ± 3.6 [SD] %) by comparison with those with normal findings (25.6 ± 3.2 [SD] %) ( P   <  0.01). ECV-CT strongly correlated with LGE mass ( r  = 0.82) and showed strong segmental correlation with ECV-MRI (basal: r  = 0.95; mid-ventricular: r = 0.91). An ECV-CT threshold of 26.9 % yielded an AUC of 0.95 (95 % CI: 0.84–1.00) for the diagnosis of myocarditis.

Conclusion

Calculation of ECV using iodine maps derived from late iodine enhancement cardiac PCD-CT images is both feasible and accurate at low radiation doses. PCD-CT appears as a promising non-invasive imaging modality for the diagnostic and prognostic assessment of acute myocarditis in the setting of chest pain.

Il testo completo di questo articolo è disponibile in PDF.

Keywords : Coronary artery disease, Computed tomography, Dual-source photon counting, Extracellular volume, Myocarditis

Abbreviation : AUC, DLP, CAD, CAD-RADS, CT, CCTA, ECG, ECV, EF, ICC, LGE, LIE, LV, LVEF, MRI, PCD, PPV, SD


Mappa


© 2025  Société française de radiologie. Pubblicato da Elsevier Masson SAS. Tutti i diritti riservati.
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 106 - N° 7-8

P. 255-263 - luglio 2025 Ritorno al numero
Articolo precedente Articolo precedente
  • Cardiac magnetic resonance imaging in the follow-up of patients with Fabry cardiomyopathy
  • Jules Senlis, Fabien Labombarda, Julien Burel, Arthur Flouriot, Sébastien Normant, Matthieu Demeyere, Olivier Lairez, Soraya El Ghannudi, Alexis Jacquier, Olivier Ghekiere, Farah Cadour, Jean-Nicolas Dacher
| Articolo seguente Articolo seguente
  • Generative T2*-weighted images as a substitute for true T2*-weighted images on brain MRI in patients with acute stroke
  • Antoine Pelcat, Alice Le Berre, Wagih Ben Hassen, Clement Debacker, Sylvain Charron, Bertrand Thirion, Laurence Legrand, Guillaume Turc, Catherine Oppenheim, Joseph Benzakoun

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.

@@150455@@ Voir plus

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2026 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.